Evrardpharma SRL
Evrardpharma reported total assets of 396,211 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 May 2026).
The score of Evrardpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets +18 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Evrardpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 11,170 € | ||||
| Equity | 294,735 € | ||||
| Cash | 187,047 € | ||||
| EBITDA | 22,111 € | ||||
| Total assets | 396,211 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 28 May 2026
- Year ended 30 Sep 2024filed on 16 May 2025
- Year ended 30 Sep 2023filed on 29 May 2024
- Year ended 30 Sep 2022filed on 03 May 2023
- Year ended 30 Sep 2021filed on 23 May 2022
Evrardpharma's financial analysis
- Solvency74.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Evrardpharma
Evrardpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0867.486.638
- VAT number
- BE0867486638
- Peppol
- Registered · 0208:0867486638 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Sep 2004
- Registered office
- 6180 Courcelles
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Evrardpharma (SRL) has been based in Courcelles since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 11,170 € and equity of 294,735 €; its revenue is not published. Its solvency stands at 74.4%, above the median of its sector (41.5%).
Companies similar to Evrardpharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Celis Retail sale of pharmaceutical products Lubbeek · balance sheet 371,497 €
- Healthy Pharmacy Retail sale of pharmaceutical products Beersel · balance sheet 468,090 €
- Diepenbeek Markt Farma Retail sale of pharmaceutical products Diepenbeek · balance sheet 505,908 €
- Astgen Leboeuf Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 378,915 €
- Benaturals Other non-specialised retail sale Aarschot · balance sheet 86,702 €
- Smart Pharma Retail sale of pharmaceutical products Ixelles · balance sheet 483,477 €
- Lifetime Energy Retail sale of pharmaceutical products Wommelgem · balance sheet 287,751 €
- Greendock Wholesale of perfume and cosmetics Keerbergen · balance sheet 544,507 €
Frequently asked questions about Evrardpharma
What is the revenue of Evrardpharma?
Evrardpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Evrardpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0867486638 for Evrardpharma, if the company is VAT-registered. Its company number (CBE) is 0867.486.638.
Where is the registered office of Evrardpharma?
According to the CBE register, the registered office of Evrardpharma is in 6180 Courcelles.
What is the equity of Evrardpharma?
At the close of the 2025 financial year, the equity of Evrardpharma amounts to 294,735 €, a solvency of 74.4% of total assets.
Who manages Evrardpharma?
The register lists 1 active mandates at Evrardpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Evrardpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →